5:35 PM
 | 
Dec 07, 2012
 |  BC Extra  |  Clinical News

Iroko reports Phase III pain data for submicron indomethacin

Iroko Pharmaceuticals LLC (Philadelphia, Pa.) said in a Phase III trial to treat post-surgical acute pain that all three doses of submicron indomethacin met the primary endpoint...

Read the full 122 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >